GR3015673T3 - Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments. - Google Patents

Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments.

Info

Publication number
GR3015673T3
GR3015673T3 GR950400817T GR950400817T GR3015673T3 GR 3015673 T3 GR3015673 T3 GR 3015673T3 GR 950400817 T GR950400817 T GR 950400817T GR 950400817 T GR950400817 T GR 950400817T GR 3015673 T3 GR3015673 T3 GR 3015673T3
Authority
GR
Greece
Prior art keywords
medicaments
compound
acetohydroxamic acid
acid compound
preparation
Prior art date
Application number
GR950400817T
Other languages
Greek (el)
English (en)
Inventor
Ulrich Dr Seipp
Werner Dr Englberger
Michael Dr Haurand
Johannes Dr Schneider
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of GR3015673T3 publication Critical patent/GR3015673T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GR950400817T 1991-07-17 1995-04-03 Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments. GR3015673T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4123613A DE4123613C1 (ru) 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
GR3015673T3 true GR3015673T3 (en) 1995-07-31

Family

ID=6436313

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400817T GR3015673T3 (en) 1991-07-17 1995-04-03 Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments.

Country Status (10)

Country Link
US (1) US5252562A (ru)
EP (1) EP0523499B1 (ru)
AT (1) ATE120460T1 (ru)
AU (1) AU644533B2 (ru)
CA (1) CA2070492A1 (ru)
DE (2) DE4123613C1 (ru)
DK (1) DK0523499T3 (ru)
ES (1) ES2073214T3 (ru)
GR (1) GR3015673T3 (ru)
HK (1) HK1005189A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954320A2 (en) * 2005-11-15 2008-08-13 Baxter International Inc. Compositions comprising lipoxygenase inhibitors and cyclodextrin
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
NZ215487A (en) * 1985-03-16 1990-01-29 Wellcome Found Aryl derivatives, pharmaceutical compositions thereof and preservation of cut flowers
GB8531839D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
US5036157A (en) * 1986-03-11 1991-07-30 Burroughs Wellcome Co. Aryl derivatives
US5026729A (en) * 1987-02-10 1991-06-25 Abbott Laboratories Lipoxygenase inhibiting compounds
CA1316935C (en) * 1987-12-09 1993-04-27 Hiromitsu Saito Hydroxamic acid derivatives
JPH0288553A (ja) * 1988-07-14 1990-03-28 Wellcome Found Ltd:The 抗炎症性アリール誘導体
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
FR2660309B1 (fr) * 1990-03-27 1992-07-17 Roussel Uclaf Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives.

Also Published As

Publication number Publication date
HK1005189A1 (en) 1998-12-24
EP0523499A1 (de) 1993-01-20
AU2036092A (en) 1993-01-28
US5252562A (en) 1993-10-12
AU644533B2 (en) 1993-12-09
ES2073214T3 (es) 1995-08-01
ATE120460T1 (de) 1995-04-15
DE59201764D1 (de) 1995-05-04
CA2070492A1 (en) 1993-01-18
DK0523499T3 (da) 1995-06-12
DE4123613C1 (ru) 1993-02-04
EP0523499B1 (de) 1995-03-29

Similar Documents

Publication Publication Date Title
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
BR9714287A (pt) Antibiótico cristalino designado solvato 6-o-metileritromicina forma 0, solvato de 6-o-metileritromicina forma 0, composição, processos para tratamento de infecções bacterianas em um mamìfero hospedeiro com necessidade de tal tratamento e para preparação de solvato de 6-o-metileritomicina a forma 0, 6-o-metileritromicina forma 0--etanolato, suspensão para administração oral, e, complexo de solvato de 6-o-metileritromicina a forma 0-carbÈmero.
GB1003595A (en) Oral compositions for caries prophylaxis
GR3015673T3 (en) Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments.
US4349466A (en) Peptide, process for preparation thereof and use thereof
ZA876740B (en) Derivatives of 4,5-dihydrooxazoles,a process for their preparation and their use
JPS5540621A (en) Novel aminoglycoside derivative
ATE124035T1 (de) Substituierte 3,4-dihydronaphthaline, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen.
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
JPS6422893A (en) Drug composition, lactosyl compound and its production
ES442505A1 (es) Procedimiento de preparacion de la 4-0-n2',6'-diamino-2',3',6' - tridesoxi-alfa, d-ribohexopiranosiln6-0 - n3" - metila-mino-3",4",6"tridesoxi alfa,d-xilohexopiranosiln2-desoxies- treptamina.
ES461764A1 (es) Procedimiento para preparar oximas derivadas del acido 3- carbamoiloximetil-7-aminotiazolilacetamido cefalosporanico.
EP0462948A3 (en) Pharmaceutical compositions comprising 3-amino-epsilon-caprolactames for enhancing learning and memory
NZ218892A (en) Nitrogen-arylmethoxy thiophene derivatives and pharmaceutical compositions
DE3461187D1 (en) N-cyclopropylmethyl-2-oxo-3-diparamethoxyphenyl-5,6-triazines, process for its preparation and their use as pharmaceutical preparations
GB1562902A (en) Pharmaceutical compositions containing clavulanic acid
JPS57116045A (en) Dithiocarbamate, its preparation and injurious organism exterminatory agent consisting of said dithiocarbamate
JPS55115896A (en) Novel antibiotic substance and its preparation
ES8504816A1 (es) Un procedimiento de preparacion de un derivado de cefalosporina
JPS577418A (en) Cephalosporin agent composition for oral administration
KR830009116A (ko) 세팔로스포린 유도체의 제조방법
JPS54145638A (en) Novel derivative of xk-62-2
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
GB1108320A (en) Improvements in or relating to anti-microbial compositions
IT1248068B (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.